A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report

Introduction: Chronic lymphocytic leukemia (CLL), the most common leukemia in Western countries, is a mature B-cell chronic lymphoproliferative disorder characterized by the accumulation of neoplastic CD5+ B lymphocytes, functionally incompetent and usually monoclonal in origin, in bone marrow, lymph nodes and blood. Diagnosis occurs predominantly in elderly patients, with a median age reported between 67 and 72 years. CLL has a heterogeneous clinical course, which can vary from indolent to, less frequently, aggressive forms. Early-stage asymptomatic CLL patients do not require immediate therapeutic intervention, but only observation; treatment is necessary for patients with advanced disease or when “active disease” is observed. The most frequent autoimmune cytopenia (AIC) is autoimmune haemolytic anaemia (AHIA). The main mechanisms underlying the appearance of AIC in CLL are not fully elucidated, the predisposition of patients with CLL to suffering autoimmune complications is variable and autoimmune cytopenia can precede, be concurrent, or follow the diagnosis of CLL. Case presentation: A 74-year-old man was admitted to the emergency room following the finding of severe macrocytic anaemia during blood tests performed that same day, in particular the patient showed a profound asthenia dating back several months. The anamnesis was silent and the patient was not taking any medications. The blood examination showed an extremely high White Blood Cell count and findings of AIHA in CLL-type mature B-cell lymphoproliferative neoplasia. Genetic investigations: Conventional karyotyping was performed and it obtained a trisomy 8 and an unbalanced translocation between the short arm of chromosome 6 and the long arm of chromosome 11, concurrent with interstitial deletions in chromosomes 6q and 11q that could not be defined in detail. Molecular cytogenetics (FISH) analyses revealed Ataxia Telangiectasia Mutated (ATM) monoallelic deletion (with loss of ATM on derivative chromosome 11) and retained signals for TP53, 13q14 and centromere 12 FISH probes. TP53 and IGHV were not mutated. Array-CGH confirmed trisomy of the entire chromosome 8 and allowed us to resolve in detail the nature of the unbalanced translocation, revealing multiple regions of genomic losses on chromosomes 6 and 11. Discussion: The present case report is an unusual CLL case with complex karyotype and refinement of all breakpoints at the gene level by the genomic array. From a genetic point of view, the case under study presented several peculiarities. Conclusions: We report the genetic findings of a CLL patient with abrupt disease onset, so far responding properly to treatments despite the presence of distinct genetic adverse traits including ATM deletion, complex karyotype and chromosome 6q chromoanagenesis event. Our report confirms that interphase FISH alone is not able to provide an overview of the whole genomic landscape in selected CLL cases and that additional techniques are required to reach an appropriate cytogenetic stratification of patients.

[1]  B. Biderman,et al.  Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias , 2023, Leukemia.

[2]  K. Plevova,et al.  Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability , 2021, Frontiers in Oncology.

[3]  L. Laurenti,et al.  Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review , 2021, Cancers.

[4]  S. Beà,et al.  Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia , 2021, Genes, chromosomes & cancer.

[5]  W. Barcellini,et al.  Autoimmune Complications in Hematologic Neoplasms , 2021, Cancers.

[6]  R. Foà,et al.  Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. , 2021, Blood.

[7]  J. Puechberty,et al.  Chromoanagenesis, the mechanisms of a genomic chaos. , 2021, Seminars in cell & developmental biology.

[8]  W. Barcellini,et al.  How I treat warm autoimmune hemolytic anemia. , 2021, Blood.

[9]  J. Rupa-Matysek,et al.  Autoimmune hemolytic anemia: current knowledge and perspectives , 2020, Immunity & ageing : I & A.

[10]  L. Bullinger,et al.  Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. , 2020, Blood.

[11]  E. van den Berg,et al.  European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH) , 2020, Leukemia.

[12]  M. Boccadoro,et al.  Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs , 2020, Cancers.

[13]  W. Barcellini,et al.  Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects , 2020, Frontiers in Oncology.

[14]  U. Jäger,et al.  Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. , 2019, Blood reviews.

[15]  M. Hallek Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment , 2019, American journal of hematology.

[16]  S. Berentsen,et al.  Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. , 2019, Blood advances.

[17]  M. Mabed,et al.  The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia. , 2019, Hematology/oncology and stem cell therapy.

[18]  E. van den Berg,et al.  European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms , 2019, Leukemia.

[19]  A. Kater,et al.  Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations , 2018, Expert review of hematology.

[20]  S. Berentsen How I manage patients with cold agglutinin disease , 2018, British journal of haematology.

[21]  F. Carrat,et al.  Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study , 2018, Leukemia & lymphoma.

[22]  E. Koritáková,et al.  Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients , 2017, American journal of hematology.

[23]  N. Kay,et al.  How I treat autoimmune hemolytic anemia. , 2017, Blood.

[24]  C. Demir,et al.  Clinical and serological autoimmune complications in chronic lymphocytic leukemia , 2017, Wiener klinische Wochenschrift.

[25]  E. Massey,et al.  The diagnosis and management of primary autoimmune haemolytic anaemia , 2017, British journal of haematology.

[26]  F. Roudot-thoraval,et al.  A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study) , 2017, American journal of hematology.

[27]  F. Rodeghiero,et al.  Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome , 2016, Annals of Hematology.

[28]  C. Rodrigo,et al.  Rituximab in the treatment of autoimmune haemolytic anaemia , 2015, British journal of clinical pharmacology.

[29]  T. Fukuda [Pathogenesis of chronic lymphocytic leukemia]. , 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[30]  D. Consonni,et al.  Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. , 2014, Blood.

[31]  Xiao-Jie Yan,et al.  Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia , 2014, Leukemia and Lymphoma.

[32]  Cheng-Zhong Zhang,et al.  Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements , 2013, Genes & development.

[33]  L. Kjeldsen,et al.  A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia , 2013, British journal of haematology.

[34]  Michael Hallek,et al.  Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment , 2013, American journal of hematology.

[35]  P. Galieni,et al.  6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia , 2013, European journal of haematology.

[36]  M. Shen Chromoplexy: a new category of complex rearrangements in the cancer genome. , 2013, Cancer cell.

[37]  A. Neri,et al.  Autoimmune cytopenias in chronic lymphocytic leukemia , 2014, American journal of hematology.

[38]  K. Coombes,et al.  Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. , 2013, The Journal of molecular diagnostics : JMD.

[39]  R. Foà,et al.  B‐cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia , 2012, American journal of hematology.

[40]  J. Downing,et al.  High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations. , 2012, Blood.

[41]  M. Jarošová,et al.  Array-based karyotyping in chronic lymphocytic leukemia (CLL) detects new unbalanced abnormalities that escape conventional cytogenetics and CLL FISH panel. , 2012, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[42]  F. caligaris-Cappio,et al.  A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy? , 2011, Current opinion in oncology.

[43]  Hanna Göransson,et al.  Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia , 2011, Haematologica.

[44]  E. Montserrat,et al.  Chronic lymphocytic leukemia and autoimmunity: a systematic review , 2011, Haematologica.

[45]  E. Montserrat,et al.  Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. , 2010, Blood.

[46]  Deborah A. Bowen,et al.  Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis , 2009, Leukemia & lymphoma.

[47]  Deborah A. Bowen,et al.  The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma , 2008, British journal of haematology.

[48]  D. Catovsky,et al.  The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. , 2008, Blood.

[49]  K. Do,et al.  Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  F. Zaja,et al.  Trisomy 8 in chronic lymphocytic leukemia: a report of two cases. , 2007, Cancer Genetics and Cytogenetics.

[51]  F. Ferrara,et al.  Rituximab therapy for chronic lymphocytic leukemia‐associated autoimmune hemolytic anemia , 2006, American journal of hematology.

[52]  R. Foà,et al.  Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. , 2000, Blood.

[53]  L. Diehl,et al.  Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. , 1998, Seminars in oncology.

[54]  N. Chiorazzi,et al.  mechanisms of disease Chronic Lymphocytic Leukemia , 2010 .

[55]  W. Dameshek Special Article: Chronic Lymphocytic Leukemia—an Accumulative Disease of Immunologically Incompetent Lymphocytes , 1967 .

[56]  C. Moreno,et al.  Autoimmune Cytopenia in CLL , 2021, Cancer journal.

[57]  J. Staaf,et al.  Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients , 2010, Leukemia.